Elevation Oncology shares owned by UBS Group
Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Elevation Oncology
Tip: Access up to 7 years of quarterly data
All positions including Elevation Oncology held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Elevation Oncology by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $69k | 129k | 0.54 |
| 2023-09-30 | $83k | 125k | 0.66 |
| 2023-06-30 | $24k | 16k | 1.52 |
| 2023-03-31 | $190 | 100 | 1.90 |
| 2022-12-31 | $1.7k | 1.8k | 0.95 |
| 2021-12-31 | $15k | 2.4k | 6.20 |
| 2021-06-30 | $14k | 1.0k | 13.40 |